Sciety

MHC-II constrains the natural neutralizing antibody response to the SARS-CoV-2 spike RBM in humans

This article has 4 authors:
1. Andrea Castro
2. Kivilcim Ozturk
3. Maurizio Zanetti
4. Hannah Carter
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Dec 28, 2020Latest activity Dec 29, 2020
Cellular events of acute, resolving or progressive COVID-19 in SARS-CoV-2 infected non-human primates

This article has 19 authors:
1. M. D. Fahlberg
2. R. V. Blair
3. L. A. Doyle-Meyers
4. C. C. Midkiff
5. G. Zenere
6. K. E. Russell-Lodrigue
7. C. J. Monjure
8. E. H. Haupt
9. T. P. Penney
10. G. Lehmicke
11. B. M. Threeton
12. N. Golden
13. P. K. Datta
14. C. J. Roy
15. R. P. Bohm
16. N. J. Maness
17. T. Fischer
18. J. Rappaport
19. M. Vaccari
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Nov 27, 2020Latest activity Jul 21, 2020
Opposing activities of IFITM proteins in SARS‐CoV‐2 infection

This article has 11 authors:
1. Guoli Shi
2. Adam D Kenney
3. Elena Kudryashova
4. Ashley Zani
5. Lizhi Zhang
6. Kin Kui Lai
7. Luanne Hall‐Stoodley
8. Richard T Robinson
9. Dmitri S Kudryashov
10. Alex A Compton
11. Jacob S Yount
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Dec 21, 2020Latest activity Aug 14, 2020
HLA class I genotypes customize vaccination strategies in immune simulation to combat COVID-19

This article has 2 authors:
1. Shouxiong Huang
2. Ming Tan
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Nov 18, 2020Latest activity Nov 20, 2020
Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate

This article has 18 authors:
1. Sandhya Bangaru
2. Gabriel Ozorowski
3. Hannah L. Turner
4. Aleksandar Antanasijevic
5. Deli Huang
6. Xiaoning Wang
7. Jonathan L. Torres
8. Jolene K. Diedrich
9. Jing-Hui Tian
10. Alyse D. Portnoff
11. Nita Patel
12. Michael J. Massare
13. John R. Yates
14. David Nemazee
15. James C. Paulson
16. Greg Glenn
17. Gale Smith
18. Andrew B. Ward
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Nov 27, 2020Latest activity Aug 11, 2020
Next generation vaccine platform: polymersomes as stable nanocarriers for a highly immunogenic and durable SARS-CoV-2 spike protein subunit vaccine

This article has 13 authors:
1. Jian Hang Lam
2. Amit Kumar Khan
3. Thomas Andrew Cornell
4. Regine Josefine Dress
5. Teck Wan Chia
6. Wen Wang William Yeow
7. Nur Khairiah Mohd-Ismail
8. Shrinivas Venkatraman
9. Kim Tien Ng
10. Yee-Joo Tan
11. Danielle E. Anderson
12. Florent Ginhoux
13. Madhavan Nallani
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Jan 25, 2021Latest activity Jan 26, 2021
Single-cell RNA sequencing of blood antigen-presenting cells in severe COVID-19 reveals multi-process defects in antiviral immunity

This article has 13 authors:
1. Melissa Saichi
2. Maha Zohra Ladjemi
3. Sarantis Korniotis
4. Christophe Rousseau
5. Zakaria Ait Hamou
6. Lucile Massenet-Regad
7. Elise Amblard
8. Floriane Noel
9. Yannick Marie
10. Delphine Bouteiller
11. Jasna Medvedovic
12. Frédéric Pène
13. Vassili Soumelis
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version May 1, 2021Latest activity Jul 25, 2020
High-resolution profiling of pathways of escape for SARS-CoV-2 spike-binding antibodies

This article has 11 authors:
1. Meghan E. Garrett
2. Jared Galloway
3. Helen Y. Chu
4. Hannah L. Itell
5. Caitlin I. Stoddard
6. Caitlin R. Wolf
7. Jennifer K. Logue
8. Dylan McDonald
9. Haidyn Weight
10. Frederick A. Matsen
11. Julie Overbaugh
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version May 1, 2021Latest activity Nov 17, 2020
Rapid development of neutralizing and diagnostic SARS-COV-2 mouse monoclonal antibodies

This article has 22 authors:
1. Asheley P. Chapman
2. Xiaoling Tang
3. Joo R. Lee
4. Asiya Chida
5. Kristina Mercer
6. Rebekah E. Wharton
7. Markus Kainulainen
8. Jennifer L. Harcourt
9. Roosecelis B. Martines
10. Michelle Schroeder
11. Liangjun Zhao
12. Anton Bryksin
13. Bin Zhou
14. Eric Bergeron
15. Brigid C. Bollweg
16. Azaibi Tamin
17. Natalie Thornburg
18. David E. Wentworth
19. David Petway
20. Dennis A. Bagarozzi
21. M. G. Finn
22. Jason M. Goldstein
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version May 6, 2021Latest activity Oct 15, 2020
Identification of HLA-A*02:01-Restricted Candidate Epitopes Derived from the Nonstructural Polyprotein 1a of SARS-CoV-2 That May Be Natural Targets of CD8 ⁺ T Cell Recognition In Vivo

This article has 2 authors:
1. Akira Takagi
2. Masanori Matsui
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Feb 10, 2021Latest activity Sep 21, 2020

Previous Page 135 of 175 Next

Immunology

MHC-II constrains the natural neutralizing antibody response to the SARS-CoV-2 spike RBM in humans

Cellular events of acute, resolving or progressive COVID-19 in SARS-CoV-2 infected non-human primates

Opposing activities of IFITM proteins in SARS‐CoV‐2 infection

HLA class I genotypes customize vaccination strategies in immune simulation to combat COVID-19

Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate

Next generation vaccine platform: polymersomes as stable nanocarriers for a highly immunogenic and durable SARS-CoV-2 spike protein subunit vaccine

Single-cell RNA sequencing of blood antigen-presenting cells in severe COVID-19 reveals multi-process defects in antiviral immunity

High-resolution profiling of pathways of escape for SARS-CoV-2 spike-binding antibodies

Rapid development of neutralizing and diagnostic SARS-COV-2 mouse monoclonal antibodies

Identification of HLA-A02:01-Restricted Candidate Epitopes Derived from the Nonstructural Polyprotein 1a of SARS-CoV-2 That May Be Natural Targets of CD8 ⁺ T Cell Recognition In Vivo*